Triterpenoids and alkaloids from the roots of Peganum nigellastrum

Natural Product Communications

Volumn 3, Issue 2, 2008, Pages 149-154

  Ma, Zhongze ^a,b   Hano, Yoshio ^b   Qiu, Feng ^c   Shao, Gang ^c   Chen, Yingjie ^c   Nomura, Taro ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TOHO UNIVERSITY   (Japan)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Alkaloid; Cytotoxicity; Epimer; Peganum nigellastrum; Triterpenoid; Zygophyllaceae

Indexed keywords

3 ALPHA ACETOXY 27 CAFFEOYLOXYLUP 20(29) EN 28 OIC ACID METHYL ESTER; 3 ALPHA HYDROXY 27 CAFFEOYLOXYLUP 20(29) EN 28 OIC ACID METHYL ESTER; 3 BETA ACETOXY 27 CAFFEOYLOXYLUP 20(29) EN 28 OIC ACID METHYL ESTER; 3 BETA HYDROXY 27 CAFFEOYLOXYLUP 20(29) EN 28 OIC ACID METHYL ESTER; ALKALOID DERIVATIVE; ANDROGEN; DEOXYVASICINONE; HARMALINE; HARMINE; HARMOL; LUOTONIN C; LUOTONIN D; TRITERPENOID; UNCLASSIFIED DRUG; VASICINONE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CYTOTOXICITY; DRUG ISOLATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PEGANUM NIGELLASTRUM; PLANT ROOT; PROSTATE CANCER; SPECTROSCOPY;

PEGANUM NIGELLASTRUM; ZYGOPHYLLACEAE;

EID: 77953969437     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0800300208     Document Type: Article

References (23)

1. Fan ZR, Yao XS. (1992) Compositions and pharmacological action of Peganum plants. Shenyang Yaoxueyuan Xuebao, 9, 144-151.
2. Duan JA, Zhou RH, Zhao SX, Wang MS, Che, CT. (1998) Studies on the chemical constituents of Peganum multisectum Maxim. I. The alkaloids from seeds and antitumor activity. Zhongguo Yaoke Daxue Xuebao, 29, 21-23.
3. Wang XW, Xie H. (1999) Antineoplastic alkaloids from Peganum harmala. Drugs of the Future, 24, 1333-1337.
4. Lamchouri F, Settaf A, Cherrah Y, Hassar M, Zemzami M, Atif N, Nadori EB, Zaid A, Lyoussi B. (2000) In vitro cell-toxicity of Peganum harmala alkaloids on cancerous cell-lines. Fitoterapia, 71, 50-54.
5. Xie JC, Zhu LL, Xu XJ. (2002) Affinitive separation and on-line identification of antitumor components from Peganum nigellastrum by coupling a chromatographic column of target analogue imprinted polymer with mass spectrometry. Analytical Chemistry, 74, 2352-2360.
6. Sobhani AM, Ebrahimi SA, Mahmoudian M. (2002) An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its ?-carboline alkaloids. Journal of Pharmacy & Pharmaceutical Sciences, 5, 18-22.
7. Xiao PG. (1993) A Pictorial Encyclopedia of Chinese Medical Herbs. Chuokoron-sha, Tokyo, Japan, 3, 125.
8. Xiao XH, Qiu GL, Wang HL, Liu LS, Zheng YL, Jia ZJ, Deng ZB. (1988) Effect of alkaloids from Paganum nigellastum on mouse ascitic hepatoma and isolated cells. Zhongguo Yaolixue Yu Dulixue Zazhi, 2, 232-234.
9. Ma ZZ, Hano Y, Nomura T, Chen YJ. (1997) Two new pyrroloquinazolinoquinoline alkaloids from Peganum nigellastrum. Heterocycles, 46, 541-546. (Pubitemid 127740634)
10. Ma ZZ, Hano Y, Nomura T, Chen YJ. (2004) Novel quinazoline-quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities. Bioorganic & Medicinal Chemistry Letters, 14, 1193-1196.
11. Cagir A, Jones SH, Gao R, Eisenhauer BM, Hecht SM. (2003) Luotonin A. A naturally occurring human DNA topoisomerase I poison. Journal of the American Chemical Society, 125, 13628-13629.
12. Ma ZZ, Hano Y, Nomura T, Chen YJ. (2000) Three new triterpenoids from Peganum nigellastrum. Journal of Natural Products, 63, 390-392.
13. Xue HZ, Lu ZZ, Konno C, Seojarto DD, Cordell GA, Fong HHS, Hodgson W. (1988) 3β-(3,4-Dihydroxycinnamoyl)-erythrodiol and 3β-(4- hydroxycinnamoyl)-erythrodiol from Larrea tridentate. Phytochemistry, 27, 233-235.
14. Sakurawi K, Yasuda F, Tozyo T, Nakamura M, Sato T, Kikuchi J, Terui Y, Ikenishi Y, Iwata T, Takahashi K, Konoike T, Mihara S, Fujimoto M. (1996) Endothelin receptor antagonist triterpenoid, myriceric acid A, isolated from Myrica cerifera, and structure activity relationships of its derivatives. Chemical & Pharmaceutical Bulletin, 44, 343-351.
15. Tchivounda HP, Koudogbo B, Besace Y, Casadevall E. (1990) Cylicodiscic acid, a dihydroxy pentacyclic triterpene carboxylic acid from Cylicodiscus gabunensis. Phytochemitry, 29, 3255-3258.
16. Rudiyansyah, Garson MJ. (2006) Secondary metabolites from the wood bark of Durio zibethinus and Durio kutejensis. Journal of Natural Products, 69, 1218-1221.
17. Ma ZZ, Hano Y, Nomura T, Chen YJ. (2000) Alkaloids and phenylpropanoids from Peganum nigellastrum. Phytochemistry, 53, 1075-1078.
18. Eiznhamer DA, Xu ZQ. (2004) Betulinic acid: A promising anticancer candidate. IDrugs, 7, 359-373.
19. Wada S, Tanaka R. (2005) Betulinic acid and its derivatives, potent DNA topoisomerase II inhibitors, from the bark of Bischofia javanica. Chemistry & Biodiversity, 2, 689-694.
20. Mukherjee R, Kumar V, Srivastava SK, Agarwal SK, Burman AC. (2006) Betulinic acid derivatives as anticancer agents: structure-activity relationship. Anti-Cancer Agents in Medicinal Chemistry, 6, 271-279.
21. Zhou JR, Yu L, Zerbini LF, Libermann TA, Blackburn GL. (2004) Progression to androgen-independent LNCaP human prostate tumors: Cellular and molecular alterations. International Journal of Cancer, 110, 800-806. (Pubitemid 38758504)
22. Jiang RW, Zhou JR, Hon PM, Li SL, Zhou Y, Li LL, Ye WC, Xu HX, Shaw PC, But PPH. (2007) Lignans from Dysosma versipellis with inhibitory effects on prostate cancer cell lines. Journal of Natural Products, 70, 283-286.
23. Nagaya H, Tobita Y, Nagae T, Itokawa H, Takeya K, Halim AF, Abdel-Halim OB. (1997) Cytotoxic triterpenes from Cleome africana. Phytochemistry, 44, 1115-1119.